World AIDS Day, December 1, 2021
End inequalities. End AIDS. End pandemics. Today, World Aids Day, we wear our virtual red ribbon, the universal symbol of support of people living with HIV/AIDS, families, caregivers, clinicians, researchers, …
A Plan for Emergency Shutdown and Reopening for a Consortium of Biobanks
The early months of the SARS-CoV-2 pandemic forced many laboratories and biobanks, including the ACSR, to develop contingency plans for biobank operations. Fear of the unknown, uncertainty and unpredictability, and …
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features
The ACSR is proud to share the latest EBV/DLBCL research from the ACSR’s own Lisa Rimsza, Alanna Maguire, and inaugural YIPA Awardee, Joo Song! EBV-positive HIV-associated diffuse large B cell …
FUNDING OPPORTUNITY ANNOUNCEMENT: AIDS and Cancer Specimen Resource (ACSR) Young Investigator Pilot Award (YIPA) for 2021
The U.S. National Cancer Institute (NCI)-funded AIDS and Cancer Specimen Resource (ACSR) is pleased to announce the release of the Young Investigator Pilot Award (YIPA) for 2021. We welcome applications …
Funding Opportunity Announcement: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- …
World Cancer Day, Februrary 4, 2021
Everyday, but most especially today, World Cancer Day, the ACSR stands up to cancer. Together, all of our actions matter and the ACSR recommits to supporting our cancer warriors in …
Case Study Using ACSR Specimens: NanoString Technologies, Inc. Webinar
Congratulations to the ACSR’s Dr. Alanna Maguire whose work was featured in a NanoString Technologies, Inc. webinar showcasing how Rosalind® was used to identify novel markers and potential therapeutic targets …
EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
Using ACSR Specimens, Colm Keane et al. give us the largest in-depth description of the biology of Primary Central Nervous Lymphoma occurring in patients with AIDS. This disease demonstrates a …
REQUEST FOR APPLICATIONS: AIDS and Cancer Specimen Resource (ACSR)/AIDS Malignancy Consortium (AMC) Latin American Regional Biospecimen Repository
• Letter of Intent required by December 30, 2020• Proposals must be submitted via e-mail in PDF or MS Word by 5 PM EST, Friday, January 29, 2021 to ssilver@gwu.edu. …
Notice of Intent to Publish a Funding Opportunity Announcement KSHV R01
Notice Number NOT-CA-20-098 Notice of Intent to Publish a Funding Opportunity Announcement for Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) The National Cancer Institute …